From Retirement to Reinvention: How Ali Frédéric Ben Amor Is Redefining Chronic Disease Management
After retiring, Ali Frédéric Ben Amor did not turn the page on his professional life. Following several decades in the pharmaceutical industry, international leadership roles, and a previous entrepreneurial venture, he chose to co-found Clario in 2023. This new initiative, dedicated to the monitoring of chronic diseases, extends a conviction that has guided his entire career: innovation only holds value when it concretely improves patients’ lives.
A Global Career in Pharmaceutical Sciences
A Doctor of Pharmaceutical Sciences from the University of Geneva, Ali Frédéric Ben Amor built an international career spanning Switzerland, Germany, and the United States. His early experiences in the pharmaceutical industry allowed him to work on international markets before he joined a young company specializing in medical analyses for clinical trials. As the company’s fourth employee, he contributed to its growth until it was acquired by the Corning Group four years later.
He then returned to the pharmaceutical sector, continuing his career at a biotechnology company where he held various roles ranging from medical affairs to strategic marketing. Following the company’s acquisition by Merck, he continued his journey within the group, rising to international leadership positions. He concluded his corporate career as Senior Vice President of Global Medical Affairs in Neurology and Immunology.
Transforming Patient Care: From Multiple Sclerosis to HIV
Among the experiences that marked his career is his participation in the development of treatments for multiple sclerosis (MS). To illustrate the impact of therapeutic advances, he summarizes his contribution with an unexpected phrase: “I transformed the neurologist’s waiting room.”
He recalls that thirty years ago, patients with MS gradually lost their mobility. Today, available treatments allow a significant portion of these patients to maintain a more autonomous life. He also highlights the progress made in HIV management, which has shifted from a largely fatal disease to a chronic condition that patients can live with thanks to modern treatments.
Retirement as a New Beginning
Upon reaching retirement age, Ali Frédéric Ben Amor did not step away from innovation. In 2023, he co-founded Clarrio with Firas Rhaiem, addressing a gap in chronic disease management: better understanding patient progression beyond medical consultations.
The project relies on collecting and leveraging data provided by patients between their medical appointments. The goal is to more accurately track the evolution of their health status and better understand their response to treatments in real-life conditions. Results observed in clinical trials do not always accurately reflect what happens once a medication is used in daily life.
To explain the value of this approach, he cites the example of a walking test used in monitoring certain neurological diseases. Results can vary based on very concrete circumstances, such as the distance walked from the parking lot to the medical office. Having more regular data allows for a better distinction between temporary fluctuations and true disease progression.
This new entrepreneurial adventure is a continuation of his pharmaceutical industry experience and reflects a unique perspective on retirement. “When you have worked your whole life and are in good shape, what do you do with the rest of your time?” he asks. Entrepreneurship is not a late discovery for him; even within large corporations, he explains that he always managed his divisions as standalone businesses, with a particular focus on innovation and new product launches. He also serves on the scientific board of another innovation-focused company.
Measuring a Career by Its Impact
Beyond the roles held and projects led, Ali Frédéric Ben Amor advocates for a work philosophy based on utility. For him, professional motivation cannot rest solely on salary, promotions, or task accumulation. It stems primarily from the ability to understand what one’s work truly contributes.
He encourages employees to ask themselves a simple question: “What have we concretely moved forward?” For example, an engineer writing code should be able to explain what their work enables and who benefits from it. According to him, this search for meaning should apply to all professions, including those whose contributions may seem less visible.
He compares this approach to sailing or a sports competition: the result is collective, but each individual must be able to identify their contribution to the common effort. Difficulties, endless meetings, and failures are part of the journey. The essence lies in knowing why one is moving forward.
For Ali Frédéric Ben Amor, professional experience is not measured solely by the number of years spent in a company or the responsibilities held. It is also judged by what has changed thanks to the work accomplished. At 68 years old, this search for impact remains clearly his primary driving force.
